Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.
This is not a financial advice!
2 upcoming catalysts on 31st of March
ER is on 27th of February - keep in mind
Pretty high volume recently
We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.
We might see a little PB to around 1.10 -1.20 where is a good entry zone - another scenario is that we break the 1.45 zone without any PB.
Keep an eye on 1.80, 2.40 and 2.90 levels, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.